Report Detail

Healthcare Global Flow Cytometry Market Industry Trends Forecast to 2025

  • RnM2874664
  • |
  • 04 February, 2019
  • |
  • Global
  • |
  • 264 Pages
  • |
  • Data Bridge Market Research
  • |
  • Healthcare

Global flow cytometry market is expected to reach a CAGR of 8.3% in the forecast period of 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Technology (Cell-Based fFlow Cytometry, Bead-Based Flow Cytometry), Products (Reagents And Consumables, Flow Cytometry Instruments, Accessories, Services), Application (Research Applications, Clinical Application, Industrial Applications), End User (Academic & Research Institutes Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Testing Laboratories, Blood Bank, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

• In technology, cell based assay segment is dominating the market and bead based growing with the highest CAGR because Flow cytometry has wide research applications such as apoptosis, b-cell, bead-based immunoassays, cell and tissue microscopy, clinical, intracellular flow, multicolor flow, stem cell and t-cell immunology. These assays are differentiated by cell based screening and bead based screening whereas the advanced cell based assays includes real-time intracellular calcium response measurements and high-content fluorescent imaging systems whereas bead based screening involves micro beads which works as the solid matrix for antibodies or proteins. And the developments of the new technologies such as high-throughput (HT) flow cytometry are extending the capabilities of cell-based screening technologies.

• In products, reagent and consumable is dominating the market and flow cytometry instruments are growing with the highest CAGR because various types of reagents are used for the flow cytometry application such as dyes, antibodies, beads and others. The antibodies are having wide application in fields of immunology, cancer and veterinary science. Other flow cytometry reagents include standards for fluorophores, cell types, and for instrument calibration. The dyes are extracted from live cells which make the process assessable for cell health and cell viability. Typically they work for the staining the nuclei of dead and live cells.

• In application, research application dominating the market and clinical application is growing with the highest CAGR because flow cytometry is used in the health research and treatment such as in the treatment of HIV infection, in case of treating leukemia and lymphoma patients not only limited to this but the technology has also have its wide usage to other application such as cross-matching organs for transplantation, apoptosis, research involving stem cells and others. In clinical applications, flow cytometer is used in various fields such as Immunophenotyping of a variety of specimens, including whole blood, bone marrow, serous cavity fluids, cerebrospinal fluid, urine, and solid tissues leading the growth of the market.

• In end user, academic & research institutes is dominating the market and growing with the highest CAGR due to flow cytometry the researchers are being assisted by various ways such as rapid examination of diverse individual cell types within a population of cells suspended in fluid. High-performance flow cytometers as well as high-speed cell sorters have their high usage in research such as HIV research, cancer, stem cell and drug discovery leading the growth of the market.

Key Market Players

The key market players for global flow cytometry market are listed below:

• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec Sysmex Partec GmbH
• BIOMÉRIEUX
• Mechatronics
• Apogee Flow Systems Ltd.
• Stratedigm, Inc.
• Sony Biotechnology Inc.
• BD.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• ACEA BIO
• Agilent Technologies
• Luminex Corporation.
• Enzo Life Sciences, Inc.
• Beckman Coulter, Inc.
• Takara Bio Inc.


TABLE OF CONTENTS

    1 INTRODUCTION 26

    • 1.1 OBJECTIVES OF THE STUDY 26
    • 1.2 MARKET DEFINITION 26
    • 1.3 OVERVIEW OF GLOBAL FLOW CYTOMETRY MARKET 27
    • 1.4 CURRENCY AND PRICING 27
    • 1.5 LIMITATION 28
    • 1.6 MARKETS COVERED 28

    2 MARKET SEGMENTATION 31

    • 2.1 MARKETS COVERED 31
    • 2.2 YEARS CONSIDERED FOR THE STUDY 32
    • 2.3 CURRENCY AND PRICING 32
    • 2.4 RESEARCH METHODOLOGY 33
    • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
    • 2.6 SECONDARY SOURCES 37
    • 2.7 ASSUMPTIONS 37

    3 EXECUTIVE SUMMARY 38

      4 PREMIUM INSIGHTS 41

        5 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY 43

        • 5.1 OVERVIEW 44
        • 5.2 CELL-BASED FLOW CYTOMETRY 45
        • 5.3 BEAD-BASED FLOW CYTOMETRY 46

        6 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCTS 47

        • 6.1 OVERVIEW 48
        • 6.2 REAGENTS AND CONSUMABLES 50
          • 6.2.1 ANTIBODIES 51
          • 6.2.2 DYES 51
          • 6.2.3 BEADS 51
          • 6.2.4 OTHERS 51
        • 6.3 FLOW CYTOMETRY INSTRUMENTS 52
          • 6.3.1 CELL ANALYZERS 53
          • 6.3.2 CELL SORTERS 53
        • 6.4 ACCESSORIES 54
          • 6.4.1 FILTERS 55
          • 6.4.2 LASER DEVICE 55
          • 6.4.3 DETECTORS 55
          • 6.4.4 OTHERS 55
        • 6.5 SERVICES 56

        7 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION 57

        • 7.1 OVERVIEW 58
        • 7.2 RESEARCH APPLICATIONS 59
          • 7.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY 60
            • 7.2.1.1 DRUG DISCOVERY 61
            • 7.2.1.2 STEM CELL RESEARCH 61
            • 7.2.1.3 IN VITRO TOXICITY TESTING 61
          • 7.2.2 IMMUNOLOGY 61
          • 7.2.3 APOPTOSIS 62
          • 7.2.4 CELL SORTING/ SCREENING 62
          • 7.2.5 CELL CYCLE ANALYSIS 62
          • 7.2.6 CELL TRANSFECTION/VIABILITY 62
          • 7.2.7 CELL COUNTING 63
          • 7.2.8 OTHERS 63
        • 7.3 CLINICAL APPLICATIONS 64
          • 7.3.1 CANCER 65
          • 7.3.2 HEMATOLOGY 65
          • 7.3.3 IMMUNODEFICIENCY DISEASES 65
          • 7.3.4 ORGAN TRANSPLANTATION 65
          • 7.3.5 OTHER CLINICAL APPLICATIONS 66
        • 7.4 INDUSTRIAL APPLICATIONS 66

        8 GLOBAL FLOW CYTOMETRY MARKET, BY END USER 67

        • 8.1 OVERVIEW 68
        • 8.2 ACADEMIC & RESEARCH INSTITUTES 69
        • 8.3 HOSPITALS 70
        • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 71
        • 8.5 CLINICAL TESTING LABORATORIES 72
        • 8.6 BLOOD BANK 72
        • 8.7 OTHERS 73

        9 GLOBAL FLOW CYTOMETRY MARKET, BY GEOGRAPHY 74

        • 9.1 OVERVIEW 75
        • 9.2 NORTH AMERICA 80
          • 9.2.1 U.S. 87
          • 9.2.2 CANADA 91
          • 9.2.3 MEXICO 95
        • 9.3 EUROPE 99
          • 9.3.1 GERMANY 106
          • 9.3.2 FRANCE 110
          • 9.3.3 U.K. 114
          • 9.3.4 ITALY 118
          • 9.3.5 SPAIN 122
          • 9.3.6 NETHERLANDS 126
          • 9.3.7 SWITZERLAND 130
          • 9.3.8 TURKEY 134
          • 9.3.9 RUSSIA 138
          • 9.3.10 BELGIUM 142
          • 9.3.11 REST OF EUROPE 146
        • 9.4 ASIA-PACIFIC 147
          • 9.4.1 JAPAN 154
          • 9.4.2 CHINA 158
          • 9.4.3 INDIA 162
          • 9.4.4 SOUTH KOREA 166
          • 9.4.5 AUSTRALIA 170
          • 9.4.6 SINGAPORE 174
          • 9.4.7 THAILAND 178
          • 9.4.8 MALAYSIA 182
          • 9.4.9 INDONESIA 186
          • 9.4.10 PHILIPPINES 190
          • 9.4.11 REST OF ASIA-PACIFIC 194
        • 9.5 SOUTH AMERICA 195
          • 9.5.1 BRAZIL 202
          • 9.5.2 REST OF SOUTH AMERICA 206
        • 9.6 MIDDLE EAST AND AFRICA 207
          • 9.6.1 SOUTH AFRICA 214
          • 9.6.2 REST OF MIDDLE EAST & AFRICA 218

        10 GLOBAL FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE 219

        • 10.1 COMPANY SHARE ANALYSIS: GLOBAL 219
        • 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 220
        • 10.3 COMPANY SHARE ANALYSIS: EUROPE 221
        • 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 222

        11 COMPANY PROFILE 223

        • 11.1 BD. 223
          • 11.1.1 COMPANY OVERVIEW 223
          • 11.1.2 REVENUE ANALYSIS 223
          • 11.1.3 COMPANY SHARE ANAYLYSIS 224
          • 11.1.4 PRODUCT PORTFOLIO 224
          • 11.1.5 RECENT DEVELOPMENTS 227
        • 11.2 MERCK KGAA 228
          • 11.2.1 COMPANY OVERVIEW 228
          • 11.2.2 REVENUE ANALYSIS 228
          • 11.2.3 COMPANY SHARE ANAYLYSIS 229
          • 11.2.4 PRODUCT PORTFOLIO 229
          • 11.2.5 RECENT DEVELOPMENTS 230
        • 11.3 BIO-RAD LABORATORIES, INC. 231
          • 11.3.1 COMPANY OVERVIEW 231
          • 11.3.2 REVENUE ANALYSIS 231
          • 11.3.3 COMPANY SHARE ANAYLYSIS 232
          • 11.3.4 PRODUCT PORTFOLIO 232
          • 11.3.5 RECENT DEVELOPMENTS 233
        • 11.4 ACEA BIO 234
          • 11.4.1 COMPANY OVERVIEW 234
          • 11.4.2 GEOGRAPHICAL PRESENCE 234
          • 11.4.3 PRODUCT PORTFOLIO 235
          • 11.4.4 RECENT DEVELOPMENTS 235
        • 11.5 AGILENT TECHNOLOGIES 236
          • 11.5.1 COMPANY OVERVIEW 236
          • 11.5.2 REVENUE ANALYSIS 236
          • 11.5.3 PRODUCT PORTFOLIO 237
          • 11.5.4 RECENT DEVELOPMENTS 238
        • 11.6 APOGEE FLOW SYSTEMS LTD. 239
          • 11.6.1 COMPANY OVERVIEW 239
          • 11.6.2 PRODUCT PORFOLIO 239
        • 11.7 BECKMAN COULTER, INC. 240
          • 11.7.1 COMPANY OVERVIEW 240
          • 11.7.2 GEOGRAPHICAL PRESENCE 240
          • 11.7.3 PODUCT PORTFOLIO 241
          • 11.7.4 RECENT DEVELOPEMENTS 242
        • 11.8 BIOMÉRIEUX SA 243
          • 11.8.1 COMPANY OVERVIEW 243
          • 11.8.2 REVENUE ANALYSIS 243
          • 11.8.3 PRODUCT PORTFOLIO 244
          • 11.8.4 RECENT DEVELOPMENTS 244
        • 11.9 ENZO LIFE SCIENCES, INC. 245
          • 11.9.1 COMPANY OVERVIEW 245
          • 11.9.2 GEOGRAPHICAL PRESENCE 245
          • 11.9.3 PODUCT PORTFOLIO 246
          • 11.9.4 RECENT DEVELOPEMENTS 246
        • 11.10 LUMINEX CORPORATION. 247
          • 11.10.1 COMPANY OVERVIEW 247
          • 11.10.2 REVENUE ANALYSIS 247
          • 11.10.3 PRODUCT PORTFOLIO 248
          • 11.10.4 RECENT DEVELOPMENTS 248
        • 11.11 MECHATRONICS 249
          • 11.11.1 COMPANY OVERVIEW 249
          • 11.11.2 GEOGRAPHICAL PRESENCE 249
          • 11.11.3 PRODUCT PORTFOLIO 249
        • 11.12 MILTENYI BIOTEC 250
          • 11.12.1 COMPANY OVERVIEW 250
          • 11.12.2 GEOGRAPHICAL PRESENCE 250
          • 11.12.3 PRODUCT PORTFOLIO 251
          • 11.12.4 RECENT DEVELOPMENTS 252
        • 11.13 SONY BIOTECHNOLOGY INC. 253
          • 11.13.1 COMPANY OVERVIEW 253
          • 11.13.2 GEOGRAPHICAL PRESENCE 253
          • 11.13.3 PRODUCT PORTFOLIO 254
          • 11.13.4 RECENT DEVELOPMENTS 255
        • 11.14 STRATEDIGM, INC. 256
          • 11.14.1 COMPANY OVERVIEW 256
          • 11.14.2 PRODUCT PORTFOLIO 256
        • 11.15 SYSMEX PARTEC GMBH (A SUBSIDARY OF SYSMEX CORPORATION) 257
          • 11.15.1 COMPANY OVERVIEW 257
          • 11.15.2 GEOGRAPHICAL PRESENCE 257
          • 11.15.3 PRODUCT PORTFOLIO 258
          • 11.15.4 RECENT DEVELOPMENTS 259
        • 11.16 TAKARA BIO INC. 260
          • 11.16.1 COMPANY OVERVIEW 260
          • 11.16.2 REVENUE ANALYSIS 260
          • 11.16.3 PRODUCT PORTFOLIO 261
          • 11.16.4 RECENT DEVELOPMENTS 261
        • 11.17 THERMO FISHER SCIENTIFIC INC. 262
          • 11.17.1 COMPANY OVERVIEW 262
          • 11.17.2 REVENUE ANALYSIS 262
          • 11.17.3 PRODUCT PORTFOLIO 263
          • 11.17.4 RECENT DEVELOPMENTS 263

        12 RELATED REPORTS 264

        Summary:
        Get latest Market Research Reports on Global Flow Cytometry Market Industry Trends Forecast to 2025. Industry analysis & Market Report on Global Flow Cytometry Market Industry Trends Forecast to 2025 is a syndicated market report, published as Global Flow Cytometry Market Industry Trends Forecast to 2025. It is complete Research Study and Industry Analysis of Global Flow Cytometry Market Industry Trends Forecast to 2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,200.00
        $5,400.00
        3,313.80
        4,260.60
        3,985.80
        5,124.60
        655,662.00
        842,994.00
        354,774.00
        456,138.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report